Kyverna Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kyverna Therapeutics, Inc. quarterly Operating Lease, Payments history and growth rate from Q1 2023 to Q3 2024.
  • Kyverna Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $811K, a 34.7% increase year-over-year.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $811K +$209K +34.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $809K +$207K +34.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $624K +$59K +10.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $602K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $602K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $565K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.